Skip to main content
. Author manuscript; available in PMC: 2019 Jun 28.
Published in final edited form as: J Med Invest. 2018;65(12):64–68. doi: 10.2152/jmi.65.64

Figure 3.

Figure 3.

The difference of sFlt-1/VEGF ratios between HAPE (n=10) and control groups (n=10), as well as between HAPE patients before and after treatments. A. The sFlt-1/VEGF ratio was significantly increased 4.05 folds in HAPE patients as compared to control subjects. B. The sFlt-1/VEGF ratio in the after treatment group was significantly decreased as compared with the pretreatment group. **p<0.01.